Live Breaking News & Updates on இயந்திர சுற்றோட்ட ஆதரவு

Stay updated with breaking news from இயந்திர சுற்றோட்ட ஆதரவு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Axon Therapies Announces Chad Hoskins As Chief Executive Officer


 
SANTA CLARA, Calif., July 21, 2021 /PRNewswire/ Axon Therapies, a private company focused on addressing a root cause of heart failure, today announced the appointment of seasoned medical device executive Chad Hoskins as Chief Executive Officr (CEO). Mr. Hoskins will lead the company as it transitions from early development towards regulatory clearance and commercialization of its novel heart failure treatment, splanchnic ablation for volume management (SAVM), using the Satera™ Ablation System.
Axon is poised to disrupt the heart failure market by treating a root cause of the disease rather than simply addressing patient symptoms.  We are very pleased with our initial data demonstrating the potential of SAVM to improve the quality of life of heart failure patients with preserved ejection fraction, commented Howard Levin, MD, Co-founder of Axon Therapies and Deerfield Catalyst, a medtech innovation hub. Chad s deep understanding of the heart failure market and pro ....

United States , Howard Levin , Heart Failure Society Of America , Columbia University , Public Health , Wharton School Of Business , Georgetown University , Division Vice , University Of Pennsylvania , Mckinsey Company , Business Administration , Axon Therapies Inc , Chad Hoskins , Chief Executive Officr , Axon Therapies , Deerfield Catalyst , General Manager , Vice President , Outset Medial , Division Vice President , Heart Failure Therapies , Mechanical Circulatory Support , Wharton School , Device Evaluation , Heart Failure Society , Ablation System ,